Longeveron Inc.(NASDAQ:LGVN) 
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cel...
Website: http://www.longeveron.com
Founded: 2014
CEO: Geoffrey Green
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.41
H 1.43
L 1.30
C 1.40
V 143,169
10EMA 1.40
20EMA 1.40
60EMA 1.40
120EMA 1.40
250EMA 1.40